早期不同剂量肠内营养对急性呼吸衰竭患者预后的影响
该前瞻性研究纳入44例急性呼吸衰竭机械通气患者,分为滋养型喂养组(n=23)和标准剂量喂养组(n=21),均经鼻胃管在机械通气24小时内启动肠内营养并持续7天,蛋白质供给均为1.2-1.6 g×kg-1×d-1。滋养型组非蛋白热量为41.84-83.68 kJ×kg-1×d-1,标准剂量组为104.60-125.50 kJ×kg-1×d-1。结果显示两组机械通气时间、ICU住院时间、总住院时间、28天新发感染率和60天生存率均无显著差异,但滋养型组第2天起空腹血糖显著更低,高血糖发生率26.1% vs 66.7%,喂养不耐受发生率26.1% vs 47.6%。结论认为初始滋养型肠内营养临床结局与早期标准剂量相似,但高血糖和胃肠道不耐受更少。
要点
- 急性呼吸衰竭机械通气患者初始滋养型肠内营养(非蛋白热量41.84-83.68 kJ×kg-1×d-1)与标准剂量(104.60-125.50 kJ×kg-1×d-1)相比,60天生存率无显著差异(65.2% vs 66.7%)。
- 滋养型组高血糖发生率显著低于标准剂量组(26.1% vs 66.7%,P<0.05),第2天起空腹血糖显著更低(8.58±2.37 vs 10.93±3.75 mmol/L)。
- 滋养型组喂养不耐受发生率显著低于标准剂量组(26.1% vs 47.6%,P<0.05)。
- 两组机械通气时间、ICU住院时间、总住院时间、28天新发感染率均无显著差异。
- 两组蛋白质供给均为1.2-1.6 g×kg-1×d-1,肠内营养均经鼻胃管在机械通气24小时内启动并持续7天。
适用人群与场景
- 纳入标准:2015年9月至2017年2月杭州市中医院重症医学科收治的急性呼吸衰竭接受机械通气的患者,共44例。
- 分组:滋养型喂养组(研究组)23例,标准剂量喂养组(对照组)21例。
处置流程与药物剂量
- 两组均经鼻胃管在机械通气24小时内启动肠内营养支持,连续7天,蛋白质供给均为1.2-1.6 g×kg-1×d-1。
- 滋养型喂养组(研究组):按非蛋白热量41.84-83.68 kJ×kg-1×d-1计算肠内营养量。
- 标准剂量喂养组(对照组):按非蛋白热量104.60-125.50 kJ×kg-1×d-1计算肠内营养量。
研究设计与关键结果
- 研究类型:前瞻性研究;样本量44例;人群:急性呼吸衰竭机械通气患者;干预:滋养型肠内营养(非蛋白热量41.84-83.68 kJ×kg-1×d-1)vs 标准剂量肠内营养(非蛋白热量104.60-125.50 kJ×kg-1×d-1),均经鼻胃管在机械通气24小时内启动并持续7天,蛋白质供给均为1.2-1.6 g×kg-1×d-1。
- 肠内营养供给量:3天内研究组1710.58±703.96 kJ/d vs 对照组4152.79±1334.65 kJ/d;7天研究组2471.28±815.50 kJ/d vs 对照组5058.08±875.25 kJ/d,两组比较P<0.05。
- 空腹血糖:治疗第2天研究组8.58±2.37 mmol/L vs 对照组10.93±3.75 mmol/L,持续至第7天研究组8.96±1.76 mmol/L vs 对照组10.97±4.11 mmol/L,两组比较P<0.05。
- 高血糖发生率:研究组26.1%(6/23) vs 对照组66.7%(14/21),P<0.05。
- 喂养不耐受发生率(治疗2天至7天):研究组26.1% vs 对照组47.6%,P<0.05。
- 机械通气时间(天):研究组15.04±6.75 vs 对照组16.14±8.51;ICU住院时间(天):研究组16.52±6.89 vs 对照组17.24±7.67;总住院时间(天):研究组26.35±9.69 vs 对照组25.33±7.73;28天新发感染率:研究组26.1%(6/23) vs 对照组42.9%(9/21);60天生存率:研究组65.2%(15/23) vs 对照组66.7%(14/21);以上两组比较均P>0.05。
- 肠内营养治疗7天后肌酐身高指数及肠内营养前后血清白蛋白水平两组比较均无统计学显著差异。
证据类型、等级与局限
- 证据类型:前瞻性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于急性呼吸衰竭机械通气患者,作者认为初始滋养型肠内营养(非蛋白热量41.84-83.68 kJ×kg-1×d-1)临床结局与早期标准剂量肠内营养(非蛋白热量104.60-125.50 kJ×kg-1×d-1)相似,但高血糖和胃肠道不耐受发生率更低。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To observe the impact of initial low-dose (trophic type) enteral nutrition (EN) support on mechanical ventilation (MV) time, the incidence of complications and survival rate in patients with acute respiratory failure (ARF).
METHODS: A prospective study was conducted. Forty-four patients with ARF undergoing MV admitted to Department of Critical Care Medicine of Hangzhou Traditional Chinese Medical Hospital from September 2015 to February 2017 were enrolled, and they were divided into a trophic feeding group (n = 23, study group) and a standard-dose feeding group (n = 21, control group). In the two groups, the EN support feeding was given to the patients through a nasogastric tube within 24-hour MV for consecutive 7 days, the protein supply to each one of all of them was 1.2-1.6 g×kg-1×d-1. The study group received EN according to non-protein calories of 41.84-83.68 kJ×kg-1×d-1 to calculate, while the control group accepted EN according to non-protein calories of 104.60-125.50 kJ×kg-1×d-1 to calculate. The serum albumin (Alb) and fasting blood glucose (FBG) levels were measured in two groups 1 day before EN treatment and at 1, 2, 3, 7 days of treatment, and the energy levels in initial 3 days and 7 days of MV and the 24-hour urine creatinine (UCr) level on the 7th day after treatment were recorded. The creatinine-height index (CHI, CHI = actual UCr/standard UCr) was calculated. The incidence of intestinal intolerance (vomiting, gastric retention, diarrhea, gastrointestinal bleeding, etc.) in 7 days of treatment, MV time, the length of stay in ICU, the total length of stay in the hospital and the 28-day incidence of new infections (pulmonary, hematogenous, urinary, abdominal, and other infections) and 60-day survival rate were observed between the two groups.
RESULTS: The EN supplies within 3 days and 7 days in the study group were significantly lower than those in the control group [within 3 days (kJ/d): 1 710.58±703.96 vs. 4 152.79±1 334.65, 7 days (kJ/d): 2 471.28±815.50 vs. 5 058.08±875.25, both P < 0.05]; there were no statistically significant differences in CHI after EN therapy for 7 days and serum Alb levels before and after EN between the two groups. FBG level of the study group was significantly lower than that of the control group since the 2nd day of treatment (mmol/L: 8.58±2.37 vs. 10.93±3.75), and continued to the 7th day (mmol/L: 8.96±1.76 vs. 10.97±4.11, both P < 0.05), the incidence of elevated blood glucose was also significantly lower than that of the control group [26.1% (6/23) vs. 66.7% (14/21), P < 0.05]. The incidence of feeding intolerance in the study group was significantly lower than that in the control group from 2 days of treatment till 7 days (26.1% vs. 47.6%, P < 0.05). There were no statistically significant differences in MV time (days: 15.04±6.75 vs. 16.14±8.51), the length of stay in ICU (days: 16.52±6.89 vs. 17.24±7.67), total length of stay in hospital (days: 26.35±9.69 vs. 25.33±7.73), 28-day new infection rate [26.1% (6/23) vs. 42.9% (9/21)] and 60-day survival rate [65.2% (15/23) vs. 66.7% (14/21)] between the study and control groups (all P > 0.05).
CONCLUSIONS: Initial trophic EN feeding results in clinical outcomes similar to those of early standard-dose EN feeding in MV patients with ARF, but the former one has less incidence of high blood sugar and more satisfactory gastrointestinal tolerance situation.
参考来源
- Gao J, Wang Q. [Effect of early use of different doses of enteral nutrition on prognosis of patients with acute respiratory failure]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 29151417. doi:10.3760/cma.j.issn.2095-4352.2017.11.010
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。